Nektar Therapeutics
-
Ticker
NKTR
-
Industry
Drug Delivery More
-
Sector
Healthcare More
- 501-1000 Employees
- Based in San Francisco, California
Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. The company’s product pipeline consists of drug candidates across various therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology.
Nektar Therapeutics
Most Recent Annual Report
MOST RECENT
2021 Annual Report and Form 10K
Older/Archived Annual Reports